{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:45:05Z","timestamp":1793832305914,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05648-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:03:09Z","timestamp":1758877389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical and biological profiles associated with the time of occurrence of citrate accumulation in patients receiving continuous renal replacement therapy"],"prefix":"10.1186","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1406-4067","authenticated-orcid":false,"given":"Frank","family":"Bidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Darnajoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Fellahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Aubrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Dailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"5648_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411\u201323.","journal-title":"Intensive Care Med"},{"key":"5648_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/cc5937","volume":"11","author":"M Joannidis","year":"2007","unstructured":"Joannidis M, van Oudemans- Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11:218.","journal-title":"Crit Care"},{"key":"5648_CR3","first-page":"1","volume":"2","author":"K Disease","year":"2012","unstructured":"Disease K. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. 2012;2:1.","journal-title":"KDIGO. Clinical Practice Guideline for Acute Kidney Injury"},{"key":"5648_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, K\u00fcllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324:1629.","journal-title":"JAMA"},{"key":"5648_CR5","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","volume":"41","author":"M Bai","year":"2015","unstructured":"Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41:2098\u2013110.","journal-title":"Intensive Care Med"},{"key":"5648_CR6","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1093\/ndt\/gfr106","volume":"26","author":"F Mariano","year":"2011","unstructured":"Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, et al. Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant. 2011;26:3882\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"5648_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/cc11645","volume":"16","author":"HM Oudemans-van Straaten","year":"2012","unstructured":"Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice. Crit Care Lond Engl. 2012;16:249.","journal-title":"Crit. Care Lond. Engl."},{"key":"5648_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","volume":"21","author":"AG Schneider","year":"2017","unstructured":"Schneider AG, Journois D, Rimmel\u00e9 T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care. 2017;21:281.","journal-title":"Crit Care"},{"key":"5648_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/00003246-200104000-00010","volume":"29","author":"H-U Meier-Kriesche","year":"2001","unstructured":"Meier-Kriesche H-U, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med. 2001;29:748\u201352.","journal-title":"Crit Care Med"},{"key":"5648_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer H-H, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29:265\u201371.","journal-title":"J Crit Care"},{"key":"5648_CR11","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc11363","volume":"16","author":"A Link","year":"2012","unstructured":"Link A, Klingele M, Speer T, Rbah R, P\u00f6ss J, Lerner-Gr\u00e4ber A, et al. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care. 2012;16:R97.","journal-title":"Crit Care"},{"key":"5648_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0885066617701068","volume":"34","author":"J-N Tan","year":"2019","unstructured":"Tan J-N, Haroon SWP, Mukhopadhyay A, Lau T, Murali TM, Phua J, et al. Hyperlactatemia predicts citrate intolerance with regional citrate anticoagulation during continuous renal replacement therapy. J Intensive Care Med. 2019;34:418\u201325.","journal-title":"J Intensive Care Med"},{"key":"5648_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcrc.2020.06.009","volume":"59","author":"PM Honore","year":"2020","unstructured":"Honore PM, Rimmel\u00e9 T. Total-to-ionized calcium ratio, taken alone, is no longer valid to diagnose citrate accumulation! What additional parameters should we consider to strengthen the utility of this ratio? J Crit Care. 2020;59:172\u20135.","journal-title":"J. Crit. Care"},{"key":"5648_CR14","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","volume":"31","author":"L Kramer","year":"2003","unstructured":"Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med. 2003;31:2450\u20135.","journal-title":"Crit Care Med"},{"key":"5648_CR15","first-page":"123","volume":"109","author":"R Apsner","year":"1997","unstructured":"Apsner R, Schwarzenhofer M, Derfler K, Zauner C, Ratheiser K, Kranz A. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr. 1997;109:123\u20137.","journal-title":"Wien Klin Wochenschr"},{"key":"5648_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05867-8","volume":"12","author":"P Thanapongsatorn","year":"2022","unstructured":"Thanapongsatorn P, Chaijamorn W, Sirivongrangson P, Tachaboon S, Peerapornratana S, Lumlertgul N, et al. Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT. Sci Rep. 2022;12:1815.","journal-title":"Sci Rep"},{"key":"5648_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13054-015-1066-7","volume":"19","author":"T Slowinski","year":"2015","unstructured":"Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the liver citrate anticoagulation threshold (L-CAT) observational study. Crit Care. 2015;19:349.","journal-title":"Crit Care"},{"key":"5648_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13054-017-1870-3","volume":"21","author":"M Klingele","year":"2017","unstructured":"Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Crit Care. 2017;21:294.","journal-title":"Crit Care"},{"key":"5648_CR19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jcrc.2015.06.006","volume":"30","author":"T Lahmer","year":"2015","unstructured":"Lahmer T, Messer M, Rasch S, Beitz A, Schnappauf C, Schmid RM, et al. Sustained low-efficiency dialysis with regional citrate anticoagulation in medical intensive care unit patients with liver failure: a prospective study. J Crit Care. 2015;30:1096\u2013100.","journal-title":"J. Crit. Care"},{"key":"5648_CR20","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/ndt\/gfr510","volume":"27","author":"FH Saner","year":"2012","unstructured":"Saner FH, Treckmann JW, Geis A, Losch C, Witzke O, Canbay A, et al. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant. 2012;27:1651\u20137.","journal-title":"Nephrol. Dial. Transplant"},{"key":"5648_CR21","first-page":"15","volume":"1","author":"J Pible","year":"2024","unstructured":"Pible J, Bidar F, Chardon N, Cerro V, Ichai C, Monard C, et al. Anticoagulation strategies for continuous renal replacement therapy in France. A survey prac Blood Purif. 2024;1:15.","journal-title":"A survey prac. Blood Purif."},{"key":"5648_CR22","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/CCM.0000000000002501","volume":"45","author":"D Khadzhynov","year":"2017","unstructured":"Khadzhynov D, Dahlinger A, Schelter C, Peters H, Kindgen-Milles D, Budde K, et al. Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation. Crit Care Med. 2017;45:e941\u20136.","journal-title":"Crit. Care Med."},{"key":"5648_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcrc.2020.05.005","volume":"59","author":"W Boer","year":"2020","unstructured":"Boer W, Van Tornout M, Solmi F, Willaert X, Schetz M, Oudemans-van SH. Determinants of Total\/ionized Calcium in patients undergoing citrate CVVH: A retrospective observational study. J Crit Care. 2020;59:16\u201322.","journal-title":"J. Crit. Care"},{"key":"5648_CR24","doi-asserted-by":"publisher","first-page":"R162","DOI":"10.1186\/cc11485","volume":"16","author":"C Schulthei\u00df","year":"2012","unstructured":"Schulthei\u00df C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, et al. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care. 2012;16:R162.","journal-title":"Crit Care"},{"key":"5648_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2317-9","volume":"23","author":"W Zhang","year":"2019","unstructured":"Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care. 2019;23:22.","journal-title":"Crit Care"},{"key":"5648_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/cc11180","volume":"16","author":"B Meijers","year":"2012","unstructured":"Meijers B, Laleman W, Vermeersch P, Nevens F, Wilmer A, Evenepoel P. A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the molecular adsorbents recirculating system. Crit Care. 2012;16:R20.","journal-title":"Crit Care"},{"key":"5648_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/CCM.0b013e3181fee8a4","volume":"39","author":"P Faybik","year":"2011","unstructured":"Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk G-C, et al. Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med. 2011;39:273\u20139.","journal-title":"Crit Care Med"},{"key":"5648_CR28","doi-asserted-by":"publisher","unstructured":"Honor\u00e9 PM, Rimmel\u00e9 T, Joannes-Boyau O. Citrate anticoagulation for continuous renal replacement therapy. Intensive Care Med [Internet]. [cited 2024 Aug 30]; Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00134-024-07531-3(2024).","DOI":"10.1007\/s00134-024-07531-3(2024"},{"key":"5648_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/cc11492","volume":"16","author":"S Patel","year":"2012","unstructured":"Patel S, Wendon J. Regional citrate anticoagulation in patients with liver failure - time for a rethink? Crit Care. 2012;16:153.","journal-title":"Crit Care"},{"key":"5648_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00134-015-4127-0","volume":"42","author":"SA Haas","year":"2016","unstructured":"Haas SA, Lange T, Saugel B, Petzoldt M, Fuhrmann V, Metschke M, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016;42:202\u201310.","journal-title":"Intensive Care Med"},{"key":"5648_CR31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1159\/000491057","volume":"43","author":"Y Yu","year":"2018","unstructured":"Yu Y, Peng S, Cen Z, Cai J, Wang W, Tang Y, et al. Applying regional citrate anticoagulation in continuous renal replacement therapy for acute kidney injury patients with acute liver dysfunction: a retrospective observational study. Kidney Blood Press Res. 2018;43:1065\u201374.","journal-title":"Kidney Blood Press Res"},{"key":"5648_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/j.ajkd.2006.07.016","volume":"48","author":"GR Hetzel","year":"2006","unstructured":"Hetzel GR, Taskaya G, Sucker C, Hennersdorf M, Grabensee B, Schmitz M. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis. 2006;48:806\u201311.","journal-title":"Am J Kidney Dis"},{"key":"5648_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","volume":"97","author":"JG O\u2019Grady","year":"1989","unstructured":"O\u2019Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439\u201345.","journal-title":"Gastroenterology"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05648-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:03:10Z","timestamp":1758877390000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05648-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5648"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05648-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the\n                      Hospices Civils de Lyon\n                      (\n                      Comit\u00e9 Scientifique et Ethique des HCL\n                      , CSE-HCL \u2013 IRB 00013204) approved the study (ref. 23\u20135184). The research was conducted in accordance with the Declaration of Helsinki. All participants or their family members received an information letter, and none were opposed to the use of their data for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}